KBIO LABS Inc. (KOSDAQ:038530)
South Korea · Delayed Price · Currency is KRW 3,785.00
-175.00 (-4.42%)
At close: Oct 2, 2026
KBIO LABS Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19,562 | 27,835 | 25,409 | 32,455 | 36,903 | 107,382 | |
Market Cap Growth | -32.52% | 9.54% | -21.71% | -12.05% | -65.63% | 343.52% |
Enterprise Value | 28,042 | 24,513 | 39,130 | 31,170 | -10,767 | 105,587 |
Last Close Price | 3785.00 | 6025.00 | 5500.00 | 7025.00 | 10050.00 | 32250.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.21 | 0.32 | 0.33 | 1.19 | 1.19 | 12.31 |
PB Ratio | 0.31 | 0.27 | 0.24 | 0.25 | 0.55 | 1.71 |
P/TBV Ratio | 0.49 | 0.54 | 0.45 | 0.54 | 0.59 | 1.83 |
P/FCF Ratio | 3.74 | 3.41 | - | - | 9.79 | - |
P/OCF Ratio | 3.72 | 3.40 | - | - | 9.75 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.30 | 0.28 | 0.51 | 1.14 | - | 12.11 |
EV/EBITDA Ratio | 11.71 | 14.48 | - | - | - | - |
EV/EBIT Ratio | 19.80 | 32.44 | - | - | - | - |
EV/FCF Ratio | 5.36 | 3.00 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.16 | 0.31 |
Debt / EBITDA Ratio | 0.12 | 0.35 | - | - | 10.11 | - |
Debt / FCF Ratio | 0.06 | 0.07 | - | - | 2.80 | - |
Net Debt / Equity Ratio | -0.23 | -0.63 | -0.48 | -0.42 | -0.52 | -0.59 |
Net Debt / EBITDA Ratio | -6.17 | -38.30 | 1995.55 | 424.66 | -33.08 | 8.49 |
Net Debt / FCF Ratio | -2.82 | -7.95 | 271.76 | 36.30 | -9.17 | 30.90 |
Asset Turnover | 0.98 | 0.74 | 0.59 | 0.24 | 0.37 | - |
Inventory Turnover | 19.67 | 13.65 | 15.21 | 7.94 | 10.51 | - |
Quick Ratio | 1.87 | 4.62 | 6.28 | 5.33 | 3.09 | 2.53 |
Current Ratio | 2.38 | 5.20 | 7.35 | 6.11 | 3.27 | 2.67 |
Return on Equity (ROE) | -4.12% | -4.82% | -8.49% | -12.11% | -10.81% | - |
Return on Assets (ROA) | 0.94% | 0.40% | -0.53% | -0.34% | 0.33% | - |
Return on Capital Employed (ROCE) | 2.20% | 0.70% | -1.00% | -0.50% | 0.70% | -8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -76.08% | -11.49% | -26.73% | -39.05% | -20.77% | -18.13% |
FCF Yield | 26.77% | 29.32% | -0.75% | -4.53% | 10.21% | -1.13% |
Buyback Yield / Dilution | -0.05% | - | -13.03% | -12.29% | -17.81% | -737.44% |